“genentech” Archives

in
Entry Author Date Location
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Roche Gets FDA OK for Injectable Version of Breast Cancer Drug 06/29/20 San Diego
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products 06/25/20 National
AbbVie Commits $750M to Genmab Bispecific Antibody Cancer Drug Deal 06/10/20 National
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs 05/29/20 Boston
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies 05/12/20 San Francisco
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics 04/08/20 Boston
Kymera Closes $102M Round to Bring Protein-Busting Drugs to the Clinic 03/12/20 Boston
Amunix Raises $73M to Bring Safer T Cell Engagers to Solid Tumors 03/04/20 San Francisco
ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers 03/02/20 San Francisco
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact 02/25/20 Boston
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck 12/04/19 San Francisco
Led by Gilead Veteran Riva, Glenmark’s Ichnos Steps Out on Its Own 10/15/19 New York
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards 09/10/19 National
San Diego Life Sciences Roundup: SGI-DNA, ZeaKal, DelMar Pharma & More 09/10/19 San Diego
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Skyhawk Inks Deal With Genentech for Cancer and Neuro Drug Discovery 07/16/19 Boston
Sequencing Firm Adaptive’s $300M IPO Comes With Pharma Ambitions 06/27/19 Seattle
Bayer and Arvinas Join Forces in $115M Pharma & Ag Research Alliance 06/04/19 Boston
Immunotherapy Is Now Here For Breast Cancer. What Are Its Prospects? 05/29/19 National
Tech Ethics, Regulation & Strategy: Here’s the Napa Summit Agenda 05/10/19 National
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
Ivor Royston Named Xconomy’s 2019 Lifetime Achievement Award Winner in San Diego 05/02/19 San Diego
Page 1 of 22 next page »